Headed by Jérôme Peretti, Manesq is an independent medical biology company located in Alpes-de-Haute-Provence. Backed by three sampling sites and a technical platform in Manosque, the laboratory generates €6.5 million in revenue.
The three biologists-partners, who wanted to join forces with a national partner, had appointed Pax Corporate Finance to help them with the process. After talks with major French companies, Cerba Healthcare stood out from the competition by offering a project in which Manesq would be a key player in the development of its new Cerballiance Hautes-Alpes Durance division.
Cerba Healthcare is a world leader in medical biology. With nearly 600 biologists working at its 450 local laboratories and its 150 sampling centers, the group focuses on five complementary activities:
- Specialized medical biology centered at Laboratoire Cerba,
- Local medical biology,
- Veterinary biology and genetics,
- Clinical trial biology,
- Diagnostic test biology.
Present on 5 continents, Cerba Healthcare provides care for 25 million patients each year. This acquisition will allow the group to extend its nationwide coverage by developing its new Cerballiance Hautes-Alpes Durance division based on an already well-established laboratory.
In this way, the Manesq laboratory will pursue its local development while leveraging significant synergies, particularly in the area of bacteriology.